Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer

The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumo...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 715559
Main Authors Zhang, Jiali, Tao, Ji, Gao, Ruo-Nan, Wei, Zhi-Yuan, He, Yu-Shan, Ren, Chun-Yan, Li, Qi-Chun, Liu, Yan-Shan, Wang, Ke-Wei, Yang, Gong, Qian, Chengjia, Chen, Jian-Huan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 01.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 ( CXCL9 , CXCL10 , and CXCL11 ), and C-C motif ligand 5 ( CCL5 ), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of CXCL9, CXCL10 , and CXCL11 was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of CXCL9 in tumor tissues was associated with enhanced CD8 + T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs’ correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota–host interaction in CRC.
AbstractList The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 ( , , and ), and C-C motif ligand 5 ( ), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of , and was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of in tumor tissues was associated with enhanced CD8 T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs' correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota-host interaction in CRC.
The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 (CXCL9, CXCL10, and CXCL11), and C-C motif ligand 5 (CCL5), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of CXCL9, CXCL10, and CXCL11 was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of CXCL9 in tumor tissues was associated with enhanced CD8+ T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs' correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota-host interaction in CRC.The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 (CXCL9, CXCL10, and CXCL11), and C-C motif ligand 5 (CCL5), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of CXCL9, CXCL10, and CXCL11 was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of CXCL9 in tumor tissues was associated with enhanced CD8+ T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs' correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota-host interaction in CRC.
The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 ( CXCL9 , CXCL10 , and CXCL11 ), and C-C motif ligand 5 ( CCL5 ), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of CXCL9, CXCL10 , and CXCL11 was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of CXCL9 in tumor tissues was associated with enhanced CD8 + T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs’ correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota–host interaction in CRC.
The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed to evaluate the expression of major cytotoxic T-cell trafficking chemokines (CTTCs) and chemokine-associated microbiota profiles in both tumor and adjacent normal tissues during CRC progression. We analyzed the expression of chemokine C-X-C motif ligands 9, 10, and 11 (CXCL9, CXCL10, and CXCL11), and C-C motif ligand 5 (CCL5), characterized gut mucosa-associated microbiota (MAM), and investigated their correlations in CRC patients. Our results showed that the expression of CXCL9, CXCL10, and CXCL11 was significantly higher in tumor than in adjacent normal tissues in 136 CRC patients. Notably, the high expression of CXCL9 in tumor tissues was associated with enhanced CD8+ T-cell infiltration and improved survival. Moreover, the MAM in tumor tissues showed reduction of microbial diversity and increase of oral bacteria. Microbial network analysis identified differences in microbial composition and structure between tumor and adjacent normal tissues. In addition, stronger associations between oral bacteria and other gut microbes were observed. Furthermore, the correlation analysis between the defined MAM and individual CTTCs showed that the CTTCs’ correlated operational taxonomic units (OTUs) in tumor and adjacent normal tissues rarely overlap with each other. Notably, all the enriched OTUs were positively correlated with the CTTCs in either tumor or adjacent normal tissues. Our findings demonstrated stronger interactions between oral bacteria and gut microbes, and a shifted correlation pattern between MAM and major CTTCs in tumor tissues, underlining possible mechanisms of gut microbiota–host interaction in CRC.
Author Wei, Zhi-Yuan
Chen, Jian-Huan
Gao, Ruo-Nan
Ren, Chun-Yan
Liu, Yan-Shan
He, Yu-Shan
Yang, Gong
Wang, Ke-Wei
Tao, Ji
Qian, Chengjia
Zhang, Jiali
Li, Qi-Chun
AuthorAffiliation 3 Department of Hospital Infection, Affiliated Hospital of Jiangnan University , Wuxi , China
2 Central Laboratory, The Fifth People’s Hospital of Shanghai Fudan University , Shanghai , China
4 Cancer Institute, Fudan University Shanghai Cancer Center , Shanghai , China
5 Department of General Surgery, Affiliated Hospital of Jiangnan University , Wuxi , China
1 Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University , Wuxi , China
AuthorAffiliation_xml – name: 4 Cancer Institute, Fudan University Shanghai Cancer Center , Shanghai , China
– name: 1 Laboratory of Genomic and Precision Medicine, Wuxi School of Medicine, Jiangnan University , Wuxi , China
– name: 3 Department of Hospital Infection, Affiliated Hospital of Jiangnan University , Wuxi , China
– name: 2 Central Laboratory, The Fifth People’s Hospital of Shanghai Fudan University , Shanghai , China
– name: 5 Department of General Surgery, Affiliated Hospital of Jiangnan University , Wuxi , China
Author_xml – sequence: 1
  givenname: Jiali
  surname: Zhang
  fullname: Zhang, Jiali
– sequence: 2
  givenname: Ji
  surname: Tao
  fullname: Tao, Ji
– sequence: 3
  givenname: Ruo-Nan
  surname: Gao
  fullname: Gao, Ruo-Nan
– sequence: 4
  givenname: Zhi-Yuan
  surname: Wei
  fullname: Wei, Zhi-Yuan
– sequence: 5
  givenname: Yu-Shan
  surname: He
  fullname: He, Yu-Shan
– sequence: 6
  givenname: Chun-Yan
  surname: Ren
  fullname: Ren, Chun-Yan
– sequence: 7
  givenname: Qi-Chun
  surname: Li
  fullname: Li, Qi-Chun
– sequence: 8
  givenname: Yan-Shan
  surname: Liu
  fullname: Liu, Yan-Shan
– sequence: 9
  givenname: Ke-Wei
  surname: Wang
  fullname: Wang, Ke-Wei
– sequence: 10
  givenname: Gong
  surname: Yang
  fullname: Yang, Gong
– sequence: 11
  givenname: Chengjia
  surname: Qian
  fullname: Qian, Chengjia
– sequence: 12
  givenname: Jian-Huan
  surname: Chen
  fullname: Chen, Jian-Huan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34539647$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQjVAR_aA_gAvKkUsWx9--IKEApVIrOCziaDnOeNcliYvtRey_x-mWquWAL57xvPdmNH6n1dEcZqiqVy1aESLVW-enabfCCLcr0TLG1LPqpOWcNgRjevQoPq7OU7pB5VBFCGEvqmNCGVGcipNq3-1zyOG3t_W66WAc63U0znn7w8-butvCFEoE9dcYnB8h1V2IEUaTof7u87b-AK6Uh_p6Z0MyY33tbQy9L1EXynyzz76Q_FzSMUSweamY2UJ8WT13Zkxwfn-fVd8-fVx3n5urLxeX3furxlLOcqMGOxBrW9pycGpgyDKDoVdAhOAOK-IGLgkmCAnVY4eklFZiJgW2EjkG5Ky6POgOwdzo2-gnE_c6GK_vHkLcaBOztyNoi3iP6NATwQkVhipeViFZr_qhNQ63RevdQet2108wWJhzNOMT0aeV2W_1JvzSklLMxSLw5l4ghp87SFlPPtmydjND2CWNmaCCIqVEgb5-3Ouhyd-_K4D2ACgbTymCe4C0SC8W0XcW0YtF9MEihSP-4VifTfZhGdeP_2H-AVARw7I
CitedBy_id crossref_primary_10_3390_cancers16234008
crossref_primary_10_3389_fimmu_2024_1443366
crossref_primary_10_1080_07357907_2024_2368233
crossref_primary_10_1080_00365521_2023_2228954
crossref_primary_10_3390_nu15020316
crossref_primary_10_1093_carcin_bgac063
crossref_primary_10_1186_s40168_023_01566_2
crossref_primary_10_2147_IJGM_S495139
crossref_primary_10_3390_cancers14143385
Cites_doi 10.1158/1078-0432.CCR-18-1851
10.1016/j.ccell.2017.04.003
10.1126/science.aan4236
10.1126/science.aar4060
10.3389/fmicb.2019.01261
10.1016/j.chom.2018.02.004
10.1007/s10096-017-3026-4
10.1038/s41586-019-0878-z
10.1038/s41564-018-0306-4
10.1126/science.1129139
10.1038/s41591-019-0458-7
10.1155/2016/6951091
10.2139/ssrn.3405559
10.1136/gutjnl-2017-314814
10.1056/NEJMoa051424
10.1002/cam4.934
10.3322/caac.21590
10.1038/nrmicro3344
10.1016/j.celrep.2020.03.035
10.1136/gutjnl-2020-321153
10.1136/gutjnl-2017-314219
10.1016/j.immuni.2015.01.010
10.1158/1078-0432.CCR-19-1868
10.1186/s13073-019-0621-2
10.1158/0008-5472.CAN-11-1466
10.1038/s41576-019-0113-7
10.1136/gutjnl-2018-316723
10.7150/thno.38870
10.1016/j.cell.2017.07.008
10.1038/nrc3245
10.1016/j.semcancer.2020.05.014
10.1126/science.aar2946
10.1053/j.gastro.2016.11.018
10.1080/2162402X.2016.1177690
10.1126/science.aal5240
10.1136/gutjnl-2016-313498
10.1038/nbt.2676
10.3748/wjg.v22.i11.3227
10.18632/oncotarget.3205
10.3390/cancers12061406
10.1016/S1470-2045(18)30952-5
10.1038/bjc.2013.557
10.1101/gr.126573.111
10.1016/j.chom.2013.07.012
10.1016/j.ctrv.2017.11.007
ContentType Journal Article
Copyright Copyright © 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen.
Copyright © 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen
Copyright_xml – notice: Copyright © 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen.
– notice: Copyright © 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2021.715559
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic


CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ : directory of open access journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_c06b04db376347a496aff85b9bd1af21
PMC8442671
34539647
10_3389_fimmu_2021_715559
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China-Henan Joint Fund
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c465t-9dcd3cc1416ef9d50c5a2eb9e3776f293fd683230079b2f0888c825872c80f5e3
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:26:48 EDT 2025
Thu Aug 21 18:34:48 EDT 2025
Fri Jul 11 11:57:45 EDT 2025
Thu Jan 02 22:55:39 EST 2025
Tue Jul 01 00:53:14 EDT 2025
Thu Apr 24 23:12:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords colorectal cancer
mucosa-associated bacteria
T cell trafficking
adjacent normal tissues
chemokines
tumor
Language English
License Copyright © 2021 Zhang, Tao, Gao, Wei, He, Ren, Li, Liu, Wang, Yang, Qian and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-9dcd3cc1416ef9d50c5a2eb9e3776f293fd683230079b2f0888c825872c80f5e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology
Edited by: Monica Cartelle Gestal, Louisiana State University Health Shreveport, United States
Reviewed by: Sandra J. Van Vliet, Vrije Universiteit Amsterdam, Netherlands; Graciela Alicia Cremaschi, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2021.715559
PMID 34539647
PQID 2574740997
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c06b04db376347a496aff85b9bd1af21
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8442671
proquest_miscellaneous_2574740997
pubmed_primary_34539647
crossref_primary_10_3389_fimmu_2021_715559
crossref_citationtrail_10_3389_fimmu_2021_715559
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-09-01
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Gopalakrishnan (B11) 2018; 359
Langille (B26) 2013; 31
Flemer (B35) 2018; 67
Franzosa (B31) 2019; 4
Sanchez-Alcoholado (B15) 2020; 12
Chiu (B23) 2019; 20
Rubinstein (B38) 2013; 14
Siegel (B1) 2020; 70
McQuade (B17) 2019; 20
Singh (B16) 2020; 70
Zumwalt (B12) 2015; 6
Tanoue (B18) 2019; 565
Chen (B37) 2019; 10
Gao (B34) 2017; 36
Chen (B43) 2020; 11
Gong (B32) 2016
Ding (B13) 2016; 5
Bedognetti (B27) 2013; 109
Omar Al-Hassi (B36) 2018; 67
Cremonesi (B19) 2018; 67
Angell (B29) 2020; 26
Cani (B28) 2018; 67
Yachida (B22) 2019; 25
Yachida (B25) 2016; 5
Bullman (B40) 2017; 358
Spranger (B7) 2017; 31
Yang (B20) 2017; 152
Jobin (B10) 2018; 359
Yu (B41) 2017; 170
Chung (B45) 2018; 23
Ribas (B9) 2018; 359
Gur (B39) 2015; 42
Li (B44) 2016; 22
Kostic (B21) 2012; 22
Yu (B30) 2020; 31
Chen (B42) 2020; 10
House (B6) 2020; 26
Louis (B14) 2014; 12
Tokunaga (B5) 2018; 63
Fridman (B2) 2012; 12
Pagès (B4) 2005; 353
Cheng (B33) 2020; 69
Galon (B3) 2006; 313
Hong (B8) 2011; 71
Allen (B24) 2019; 11
References_xml – volume: 26
  year: 2020
  ident: B29
  article-title: The Immunoscore: Colon Cancer and Beyond
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-1851
– volume: 31
  start-page: 711
  year: 2017
  ident: B7
  article-title: Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.04.003
– volume: 359
  start-page: 97
  year: 2018
  ident: B11
  article-title: Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients
  publication-title: Science
  doi: 10.1126/science.aan4236
– volume: 359
  year: 2018
  ident: B9
  article-title: Cancer Immunotherapy Using Checkpoint Blockade
  publication-title: Science
  doi: 10.1126/science.aar4060
– volume: 10
  year: 2019
  ident: B37
  article-title: Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-Cancer Tissues
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2019.01261
– volume: 23
  start-page: 421
  year: 2018
  ident: B45
  article-title: Bacteroides Fragilis Toxin Coordinates a Pro-Carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2018.02.004
– volume: 36
  year: 2017
  ident: B34
  article-title: C Microbiota Signature in Colorectal Cancer
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-017-3026-4
– volume: 565
  year: 2019
  ident: B18
  article-title: A Defined Commensal Consortium Elicits CD8 T Cells and Anti-Cancer Immunity
  publication-title: Nature
  doi: 10.1038/s41586-019-0878-z
– volume: 4
  start-page: 293
  year: 2019
  ident: B31
  article-title: Gut Microbiome Structure and Metabolic Activity in Inflammatory Bowel Disease
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-018-0306-4
– volume: 313
  year: 2006
  ident: B3
  article-title: Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
  publication-title: Science
  doi: 10.1126/science.1129139
– volume: 25
  year: 2019
  ident: B22
  article-title: Metagenomic and Metabolomic Analyses Reveal Distinct Stage-Specific Phenotypes of the Gut Microbiota in Colorectal Cancer
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0458-7
– start-page: 6951091
  year: 2016
  ident: B32
  article-title: Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease
  publication-title: Gastroenterol Res Pract 2016
  doi: 10.1155/2016/6951091
– volume: 11
  year: 2020
  ident: B43
  article-title: Fusobacterium Nucleatum Promotes Colorectal Cancer Metastasis by Modulating KRT7-As/Krt7
  publication-title: Gut Microbes
  doi: 10.2139/ssrn.3405559
– volume: 67
  year: 2018
  ident: B35
  article-title: The Oral Microbiota in Colorectal Cancer is Distinctive and Predictive
  publication-title: Gut
  doi: 10.1136/gutjnl-2017-314814
– volume: 353
  year: 2005
  ident: B4
  article-title: Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa051424
– volume: 5
  year: 2016
  ident: B13
  article-title: CXCL9: Evidence and Contradictions for Its Role in Tumors Progression
  publication-title: Cancer Med
  doi: 10.1002/cam4.934
– volume: 70
  start-page: 7
  year: 2020
  ident: B1
  article-title: Cancer Statistics, 2020
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21590
– volume: 12
  year: 2014
  ident: B14
  article-title: The Gut Microbiota, Bacterial Metabolites and Colorectal Cancer
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3344
– volume: 31
  start-page: 107471
  year: 2020
  ident: B30
  article-title: Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2020.03.035
– volume: 69
  year: 2020
  ident: B33
  article-title: The Role of Gut Microbiota in Cancer Treatment: Friend or Foe
  publication-title: Gut
  doi: 10.1136/gutjnl-2020-321153
– volume: 67
  start-page: 395
  year: 2018
  ident: B36
  article-title: Tumour-Associated and non-Tumour-Associated Microbiota in Colorectal Cancer
  publication-title: Gut
  doi: 10.1136/gutjnl-2017-314219
– volume: 42
  year: 2015
  ident: B39
  article-title: Binding of the Fap2 Protein of Fusobacterium Nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors From Immune Cell Attack
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.01.010
– volume: 26
  start-page: 487
  year: 2020
  ident: B6
  article-title: Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-1868
– volume: 11
  start-page: 11
  year: 2019
  ident: B24
  article-title: Impact of the Gut Microbiome on the Genome and Epigenome of Colon Epithelial Cells: Contributions to Colorectal Cancer Development
  publication-title: Genome Med
  doi: 10.1186/s13073-019-0621-2
– volume: 71
  start-page: 6997
  year: 2011
  ident: B8
  article-title: Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-Cell Infiltration and Tumor Control
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-11-1466
– volume: 20
  year: 2019
  ident: B23
  article-title: Clinical Metagenomics
  publication-title: Nat Rev Genet
  doi: 10.1038/s41576-019-0113-7
– volume: 67
  year: 2018
  ident: B28
  article-title: Human Gut Microbiome: Hopes, Threats and Promises
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-316723
– volume: 10
  year: 2020
  ident: B42
  article-title: Fusobacterium Nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression
  publication-title: Theranostics
  doi: 10.7150/thno.38870
– volume: 170
  start-page: 548
  year: 2017
  ident: B41
  article-title: Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
  publication-title: Cell
  doi: 10.1016/j.cell.2017.07.008
– volume: 12
  start-page: 298
  year: 2012
  ident: B2
  article-title: The Immune Contexture in Human Tumours: Impact on Clinical Outcome
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3245
– volume: 70
  start-page: 71
  year: 2020
  ident: B16
  article-title: Microbiome and Host Crosstalk: A New Paradigm to Cancer Therapy
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2020.05.014
– volume: 359
  year: 2018
  ident: B10
  article-title: Precision Medicine Using Microbiota
  publication-title: Science
  doi: 10.1126/science.aar2946
– volume: 152
  start-page: 851
  year: 2017
  ident: B20
  article-title: Fusobacterium Nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-Kappab, and Up-Regulating Expression of MicroRNA-21
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.11.018
– volume: 5
  start-page: e1177690
  year: 2016
  ident: B25
  article-title: CD169 Identifies an Activated CD8(+) T Cell Subset in Regional Lymph Nodes That Predicts Favorable Prognosis in Colorectal Cancer Patients
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1177690
– volume: 358
  year: 2017
  ident: B40
  article-title: Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer
  publication-title: Science
  doi: 10.1126/science.aal5240
– volume: 67
  year: 2018
  ident: B19
  article-title: Gut Microbiota Modulate T Cell Trafficking Into Human Colorectal Cancer
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-313498
– volume: 31
  year: 2013
  ident: B26
  article-title: Predictive Functional Profiling of Microbial Communities Using 16S rRNA Marker Gene Sequences
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2676
– volume: 22
  year: 2016
  ident: B44
  article-title: Association of Fusobacterium Nucleatum Infection With Colorectal Cancer in Chinese Patients
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i11.3227
– volume: 6
  year: 2015
  ident: B12
  article-title: Active Secretion of CXCL10 and CCL5 From Colorectal Cancer Microenvironments Associates With GranzymeB+ CD8+ T-Cell Infiltration
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3205
– volume: 12
  start-page: 1406
  year: 2020
  ident: B15
  article-title: The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers12061406
– volume: 20
  year: 2019
  ident: B17
  article-title: Modulating the Microbiome to Improve Therapeutic Response in Cancer
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(18)30952-5
– volume: 109
  year: 2013
  ident: B27
  article-title: CXCR3/CCR5 Pathways in Metastatic Melanoma Patients Treated With Adoptive Therapy and Interleukin-2
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2013.557
– volume: 22
  year: 2012
  ident: B21
  article-title: Genomic Analysis Identifies Association of Fusobacterium With Colorectal Carcinoma
  publication-title: Genome Res
  doi: 10.1101/gr.126573.111
– volume: 14
  start-page: 195
  year: 2013
  ident: B38
  article-title: Fusobacterium Nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/Beta-Catenin Signaling via its FadA Adhesin
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2013.07.012
– volume: 63
  year: 2018
  ident: B5
  article-title: CXCL9, CXCL10, CXCL11/CXCR3 Axis for Immune Activation - A Target for Novel Cancer Therapy
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2017.11.007
SSID ssj0000493335
Score 2.351543
Snippet The involvement of gut microbiota in T-cell trafficking into tumor tissue of colorectal cancer (CRC) remains to be further elucidated. The current study aimed...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 715559
SubjectTerms adjacent normal tissues
Adult
Aged
Biomarkers
CD8-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - metabolism
chemokines
Chemokines - metabolism
Chemotaxis, Leukocyte - immunology
colorectal cancer
Colorectal Neoplasms - etiology
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - pathology
Computational Biology - methods
Disease Progression
Disease Susceptibility
Female
Fluorescent Antibody Technique
Gastrointestinal Microbiome - immunology
Humans
Immunohistochemistry
Immunology
Male
Metagenome
Metagenomics
Middle Aged
mucosa-associated bacteria
Neoplasm Grading
Neoplasm Staging
T cell trafficking
T-Lymphocytes, Cytotoxic - immunology
T-Lymphocytes, Cytotoxic - metabolism
tumor
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUMilNH26SYsKPRXc2Nb7mG4TQmFLDwnNTViyRFw2dkm8kP33mbGcZbeU9NKbbMm20Iw031ijbwj5WNVclNrJPBYh5FzEmJvC1LnmRoMK6cAd_u-Yf5dnF_zbpbjcSPWFMWGJHjgN3JEvpCt443AicFVzI-sYtXDGNWUdxyPkFdi8DWfqV8K9jDGRtjHBCzNHsb2-XoI_WJWfFdhQ5CbdMEQjX__fQOafsZIbxuf0GXk6oUZ6nHq7T3ZC95w8SXkkVy_IarYa-qG_az09z2dhsaBggpAbAv-DU-QE6KEU6I-UoPuWzjAnxwJgJv3ZDlf0a4hQ3dA5hq_Dd-btSM8Epen8CLKu0raDS3DvYYnEGlSXm5fk4vTkfHaWTzkVcs-lGHLT-IZ5XwIOC9E0ovCiroIzgSklI9j-2EiY5Aygg3FVhDVIe3Aitaq8LqII7BXZ7fouvCEU0UU0tYK3KW6CNKKQUA4NEx6DVjNSPAyw9RPhOOa9WFhwPFAmdpSJRZnYJJOMfFo_8juxbTzW-AtKbd0QibLHG6A-dlIf-y_1yciHB5lbmFi4W1J3oV_eWljLuOJ4sDgjr5MOrD_FuGB4hDcjaks7tvqyXdO1VyN5t-aAiVT59n90_oDs4XikkLdDsjvcLMM7wEiDez9Oh3s2NBFL
  priority: 102
  providerName: Directory of Open Access Journals
Title Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/34539647
https://www.proquest.com/docview/2574740997
https://pubmed.ncbi.nlm.nih.gov/PMC8442671
https://doaj.org/article/c06b04db376347a496aff85b9bd1af21
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGEBIviDsZMBmJJ6SMXHx9QAgKY0Iq4mEVfbMSx96CsoS1qbT-e86J04qiCvFSuXUatz637zj2dwh5nRWMp6oUsU-cixn3PtaJLmLFtAIVUo6VuN4x_SbOZuzrnM8PyKa81TiBy72pHdaTmi2ak5vr9Xsw-HeYcUK8fevrq6sVpHpZeiIhPHJ9i9yGwCTRTqcj2v8ZwHCeDyU3UyFYDKrMwnPO_XfZiVQDof8-FPr3Zso_otPpfXJvhJX0Q9CDB-TAtQ_JnVBocv2IrCfrvuu7m9rS83jimoZCjELyCFwop0ga0EHL0e-hgveSTrBoRwM4lP6o-0v6yXnorugU97fDONN64G-C1njABGlZad3CW8j_wYdiD-rT4jGZnX4-n5zFY9GF2DLB-1hXtsqtTQGoOa8rnlheZK7ULpdSeAAHvhLgBXLAFrrMPDgpZSHLVDKzKvHc5U_IYdu17hmhCD-8LiTcTTLthOaJgLarcm5xV2tEks0EGzsykmNhjMZAZoIyMYNMDMrEBJlE5M32K78CHce_Lv6IUtteiEzawwfd4sKMhmlsIsqEVSU6WiYLpgVMv-KlLqu08FkakVcbmRuwPHycUrSuWy0NODsmGZ48jsjToAPboXLGczzjGxG5ox07v2W3p60vB3ZvxQA0yfToP8Z9Tu7i3w1b3l6Qw36xci8BI_Xl8bC2AK9f5unxYAW_AT5gEho
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytotoxic+T-Cell+Trafficking+Chemokine+Profiles+Correlate+With+Defined+Mucosal+Microbial+Communities+in+Colorectal+Cancer&rft.jtitle=Frontiers+in+immunology&rft.au=Zhang%2C+Jiali&rft.au=Tao%2C+Ji&rft.au=Gao%2C+Ruo-Nan&rft.au=Wei%2C+Zhi-Yuan&rft.date=2021-09-01&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=12&rft.spage=715559&rft_id=info:doi/10.3389%2Ffimmu.2021.715559&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon